|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Werewolf Therapeutics (NASDAQ: HOWL) through any online brokerage.
There are no as such competitors for Werewolf Therapeutics.
The latest price target for Werewolf Therapeutics (NASDAQ: HOWL) was reported by Evercore ISI Group on May 25, 2021. The analyst firm set a price target for 23.00 expecting HOWL to rise to within 12 months (a possible 87.45% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Werewolf Therapeutics (NASDAQ: HOWL) is $12.27 last updated Fri Jun 11 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Werewolf Therapeutics.
There is no upcoming split for Werewolf Therapeutics.
Werewolf Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.